ArticleJCI insight2019

RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.

Oghenekevwe M Gbenedio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.